| Line Item | 2024-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $120K | — | +145.0% |
| Cost of Revenue | $65K | — | — |
| Gross Profit | $55K | — | — |
| R&D Expense | $1.1M | — | — |
| SG&A Expense | $185K | +423.4% | +41.1% |
| Operating Income | -$1.6M | -1296.8% | -214.3% |
| Pre-tax Income | -$1.7M | -1308.1% |
| Line Item | 2024-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $10K | — | — |
| Accounts Receivable | $29K | — | — |
| Current Assets | $39K | +164.5% | -78.9% |
| Total Assets | $39K | +164.5% | -78.9% |
| Current Liabilities | $339K | +270.2% | +42.9% |
| Total Liabilities | $339K |
| Line Item | 2024-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$4.7M | — | -1377.9% |
| Capital Expenditures | $75K | — | — |
| Investing Cash Flow | -$75K | — | — |
| Financing Cash Flow | $4.8M | — | +869.6% |
| Free Cash Flow | -$4.7M | — | — |
| — |
| Income Tax | $8K | — | — |
| Net Income | -$1.7M | -1314.5% | -218.3% |
| EPS (Basic) | -$0.01 | — | — |
| EPS (Diluted) | -$0.01 | — | — |
| +270.2% |
| +42.9% |
| Stockholders' Equity | -$300K | -290.6% | -475.3% |